Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-42 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-42 |
filingDate |
2003-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39e84fdaeca5154acc6d2ddb6643400d |
publicationDate |
2003-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-03067220-A2 |
titleOfInvention |
A method of effecting angiogenesis by modulating the function of a novel endothelia phosphatase |
abstract |
KDR associated phosphatase (KAPh) is useful as a target to screen for agents useful for the treatment of angiogenesis mediated disorders. |
priorityDate |
2002-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |